Escherichia coli isolates causing asymptomatic bacteriuria in catheterized and noncatheterized individuals possess similar virulence properties.
Urinary tract infections (UTIs) are among the most common infectious diseases of humans, with Escherichia coli being responsible for >80% of all cases. Asymptomatic bacteriuria (ABU) occurs when bacteria colonize the urinary tract without causing clinical symptoms and can affect both catheterized patients (catheter-associated ABU [CA-ABU]) and noncatheterized patients. Here, we compared the virulence properties of a collection of ABU and CA-ABU nosocomial E. coli isolates in terms of antibiotic resistance, phylogenetic grouping, specific UTI-associated virulence genes, hemagglutination characteristics, and biofilm formation. CA-ABU isolates were similar to ABU isolates with regard to the majority of these characteristics; exceptions were that CA-ABU isolates had a higher prevalence of the polysaccharide capsule marker genes kpsMT II and kpsMT K1, while more ABU strains were capable of mannose-resistant hemagglutination. To examine biofilm growth in detail, we performed a global gene expression analysis with two CA-ABU strains that formed a strong biofilm and that possessed a limited adhesin repertoire. The gene expression profile of the CA-ABU strains during biofilm growth showed considerable overlap with that previously described for the prototype ABU E. coli strain, 83972. This is the first global gene expression analysis of E. coli CA-ABU strains. Overall, our data suggest that nosocomial ABU and CA-ABU E. coli isolates possess similar virulence profiles.
Watts
Rebecca E
RE
School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, QLD, Australia.
Hancock
Viktoria
V
Ong
Cheryl-Lynn Y
CL
Vejborg
Rebecca Munk
RM
Mabbett
Amanda N
AN
Totsika
Makrina
M
Looke
David F
DF
Nimmo
Graeme R
GR
Klemm
Per
P
Schembri
Mark A
MA
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001437:Bacteriuria / Q000382:microbiology*; D018441:Biofilms; D002408:Catheters, Indwelling / Q000382:microbiology; D024881:Drug Resistance, Bacterial / Q000235:genetics; D004926:Escherichia coli / Q000235:genetics / Q000254:growth & development / Q000472:pathogenicity; D005260:Female; D020869:Gene Expression Profiling; D005798:Genes, Bacterial; D006801:Humans; D007501:Iron / Q000378:metabolism; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D020411:Oligonucleotide Array Sequence Analysis; D010802:Phylogeny; D014546:Urinary Catheterization; D037521:Virulence Factors / Q000235:genetics; D018440:beta-Lactam Resistance / Q000235:genetics
D037521:Virulence Factors; D007501:Iron
Infect Immun. 1981 Feb;31(2):564-70
7012012
Clin Infect Dis. 2010 Mar 1;50(5):625-63
20175247
Int J Med Microbiol. 2009 Jan;299(1):53-63
18706859
Curr Opin Infect Dis. 2010 Feb;23(1):76-82
19926986
Infect Immun. 2006 Jan;74(1):615-24
16369018
PLoS Pathog. 2009 Feb;5(2):e1000305
19229321
J Infect Dis. 2002 Oct 1;186(7):1039-42
12232848
Infect Immun. 2007 Jul;75(7):3233-44
17420234
Infect Immun. 2006 Jan;74(1):781-5
16369040
Infect Immun. 1999 Feb;67(2):546-53
9916057
J Clin Microbiol. 1987 Dec;25(12):2253-7
2892855
Microbiology (Reading). 2008 Jan;154(Pt 1):167-175
18174135
Acta Paediatr Scand. 1975 May;64(3):432-6
1098383
J Infect Dis. 1998 Mar;177(3):642-50
9498443
J Infect Dis. 1982 Dec;146(6):719-23
6815281
J Clin Microbiol. 1998 Jan;36(1):115-7
9431932
J Clin Microbiol. 2006 Dec;44(12):4589-92
17065267
FEMS Immunol Med Microbiol. 2007 Oct;51(1):212-9
17645737
J Bacteriol. 1998 May;180(9):2442-9
9573197
Infect Immun. 2000 May;68(5):3040-7
10769012
J Infect Dis. 1987 Jun;155(6):1151-8
3572035
Mol Microbiol. 2000 Nov;38(3):456-64
11069670
J Urol. 2000 Mar;163(3):872-7
10687996
Infect Immun. 2007 Feb;75(2):966-76
17145952
Int J Antimicrob Agents. 2006 Aug;28 Suppl 1:S26-9
16843646
Microb Pathog. 1993 Aug;15(2):121-9
7902954
Infect Immun. 2008 Feb;76(2):695-703
18039831
N Engl J Med. 1980 Aug 7;303(6):316-8
6991947
Clin Microbiol Rev. 1991 Jan;4(1):80-128
1672263
FEMS Microbiol Rev. 1990 Mar;6(1):45-56
2186760
Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6640-5
10829079
Eur J Epidemiol. 1996 Apr;12(2):191-8
8817199
Infect Immun. 1991 Sep;59(9):2915-21
1879917
Pediatr Nephrol. 2006 Mar;21(3):376-81
16388392
Int J Antimicrob Agents. 2007 Nov;30(5):436-42
17719751
J Infect Dis. 2008 Sep 15;198(6):899-906
18643750
Appl Environ Microbiol. 2000 Oct;66(10):4555-8
11010916
J Infect Dis. 1977 Aug;136 Suppl:S151-60
330774
Infect Immun. 2000 May;68(5):2638-46
10768955
Int J Antimicrob Agents. 2006 Aug;28 Suppl 1:S91-107
16829052
J Infect Dis. 2004 Nov 15;190(10):1739-44
15499527
Microbiology (Reading). 2006 Jun;152(Pt 6):1799-1806
16735742
Clin Microbiol Rev. 2008 Jan;21(1):26-59
18202436
J Infect Dis. 1987 Jul;156(1):225-9
2885379
Cell Microbiol. 2001 Apr;3(4):255-64
11298649
J Infect Dis. 2000 Jan;181(1):261-72
10608775
J Bacteriol. 2008 Feb;190(3):1054-63
18055599
Am J Med. 1991 Sep 16;91(3B):65S-71S
1928194
Infect Immun. 2006 Jun;74(6):3565-75
16714589